Fig. 1From: The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trialPatients who underwent optimal SCR had longer TTP durations (a) than those who did not undergo optimal surgery, but there was no difference on OS (b)Back to article page